Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies

NCT03443674 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Peritoneal Malignancies

Interventions

DRUG: SCB-313

Sponsor

Clover Biopharmaceuticals AUS Pty